In summary, in this study, we provide new insights into a role of miR-155 in mediating ATO resistance in lung cancer cells by activating the Nrf2 signaling pathway, increasing cellular antioxidant capacity and promoting cell survival through modulating cellular apoptotic process. The gene discussed is NFE2L2; the disease is lung cancer.